Genetic tests: between risks and opportunities
Identifieur interne : 002195 ( Main/Corpus ); précédent : 002194; suivant : 002196Genetic tests: between risks and opportunities
Auteurs : Donato Ramani ; Chiara SavianeSource :
- EMBO reports [ 1469-221X ] ; 2010-12.
Abstract
Commercial genetic testing challenges traditional medical practice and the doctor–patient relationship. Neurodegenerative diseases may serve as the practical and ethical testing ground for the application of genomics to medicine.
Url:
DOI: 10.1038/embor.2010.177
Links to Exploration step
ISTEX:CB00405498A2F2EE7D0BD47A25168959C339EF27Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Genetic tests: between risks and opportunities</title><author><name sortKey="Ramani, Donato" sort="Ramani, Donato" uniqKey="Ramani D" first="Donato" last="Ramani">Donato Ramani</name><affiliation><mods:affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</mods:affiliation></affiliation></author><author><name sortKey="Saviane, Chiara" sort="Saviane, Chiara" uniqKey="Saviane C" first="Chiara" last="Saviane">Chiara Saviane</name><affiliation><mods:affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CB00405498A2F2EE7D0BD47A25168959C339EF27</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1038/embor.2010.177</idno><idno type="url">https://api.istex.fr/document/CB00405498A2F2EE7D0BD47A25168959C339EF27/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002195</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Genetic tests: between risks and opportunities</title><author><name sortKey="Ramani, Donato" sort="Ramani, Donato" uniqKey="Ramani D" first="Donato" last="Ramani">Donato Ramani</name><affiliation><mods:affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</mods:affiliation></affiliation></author><author><name sortKey="Saviane, Chiara" sort="Saviane, Chiara" uniqKey="Saviane C" first="Chiara" last="Saviane">Chiara Saviane</name><affiliation><mods:affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">EMBO reports</title><idno type="ISSN">1469-221X</idno><idno type="eISSN">1469-3178</idno><imprint><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2010-12">2010-12</date><biblScope unit="volume">11</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="910">910</biblScope><biblScope unit="page" to="913">913</biblScope></imprint><idno type="ISSN">1469-221X</idno></series><idno type="istex">CB00405498A2F2EE7D0BD47A25168959C339EF27</idno><idno type="DOI">10.1038/embor.2010.177</idno><idno type="ArticleID">EMBR2010177</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1469-221X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Commercial genetic testing challenges traditional medical practice and the doctor–patient relationship. Neurodegenerative diseases may serve as the practical and ethical testing ground for the application of genomics to medicine.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Donato Ramani</name><affiliations><json:string>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</json:string></affiliations></json:item><json:item><name>Chiara Saviane</name><affiliations><json:string>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</json:string></affiliations></json:item></author><articleId><json:string>EMBR2010177</json:string></articleId><language><json:string>eng</json:string></language><abstract>Commercial genetic testing challenges traditional medical practice and the doctor–patient relationship. Neurodegenerative diseases may serve as the practical and ethical testing ground for the application of genomics to medicine.</abstract><qualityIndicators><score>4.338</score><pdfVersion>1.5</pdfVersion><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>229</abstractCharCount><pdfWordCount>2990</pdfWordCount><pdfCharCount>19563</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>29</abstractWordCount></qualityIndicators><title>Genetic tests: between risks and opportunities</title><genre><json:string>article</json:string></genre><host><volume>11</volume><publisherId><json:string>EMBR</json:string></publisherId><pages><total>4</total><last>913</last><first>910</first></pages><issn><json:string>1469-221X</json:string></issn><issue>12</issue><subject><json:item><value>S&S: Health & Disease</value></json:item><json:item><value>S&S: Politics, Policy & Law</value></json:item><json:item><value>Outlook</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1469-3178</json:string></eissn><title>EMBO reports</title><doi><json:string>10.1002/(ISSN)1469-3178</json:string></doi></host><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1038/embor.2010.177</json:string></doi><id>CB00405498A2F2EE7D0BD47A25168959C339EF27</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/CB00405498A2F2EE7D0BD47A25168959C339EF27/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/CB00405498A2F2EE7D0BD47A25168959C339EF27/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/CB00405498A2F2EE7D0BD47A25168959C339EF27/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Genetic tests: between risks and opportunities</title><title level="a" type="sub" xml:lang="en">The case of neurodegenerative diseases</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>Chichester, UK</pubPlace><availability><p>WILEY</p></availability><date>2010</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Genetic tests: between risks and opportunities</title><title level="a" type="sub" xml:lang="en">The case of neurodegenerative diseases</title><author><persName><forename type="first">Donato</forename><surname>Ramani</surname></persName><affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</affiliation></author><author><persName><forename type="first">Chiara</forename><surname>Saviane</surname></persName><affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</affiliation></author></analytic><monogr><title level="j">EMBO reports</title><idno type="pISSN">1469-221X</idno><idno type="eISSN">1469-3178</idno><idno type="DOI">10.1002/(ISSN)1469-3178</idno><imprint><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2010-12"></date><biblScope unit="volume">11</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="910">910</biblScope><biblScope unit="page" to="913">913</biblScope></imprint></monogr><idno type="istex">CB00405498A2F2EE7D0BD47A25168959C339EF27</idno><idno type="DOI">10.1038/embor.2010.177</idno><idno type="ArticleID">EMBR2010177</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010</date></creation><langUsage><language ident="en">en</language></langUsage><abstract style="short"><p>Commercial genetic testing challenges traditional medical practice and the doctor–patient relationship. Neurodegenerative diseases may serve as the practical and ethical testing ground for the application of genomics to medicine.</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>Index Terms</head><item><term>S&S: Health & Disease</term></item><item><term>S&S: Politics, Policy & Law</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Outlook</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2010-06-30">Received</change><change when="2010-10-18">Registration</change><change when="2010-12">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/CB00405498A2F2EE7D0BD47A25168959C339EF27/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:lang="en" xml:id="embr2010177"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd</publisherName><publisherLoc>Chichester, UK</publisherLoc></publisherInfo><doi>10.1002/(ISSN)1469-3178</doi><issn type="print">1469-221X</issn><issn type="electronic">1469-3178</issn><idGroup><id type="product" value="EMBR"></id></idGroup><titleGroup><title type="main" sort="EMBO REPORTS">EMBO reports</title></titleGroup></publicationMeta><publicationMeta level="part" position="120"><doi>10.1002/embor.v11.12</doi><copyright ownership="publisher">Copyright © 2013 Wiley Periodicals, Inc</copyright><numberingGroup><numbering type="journalVolume" number="11">11</numbering><numbering type="journalIssue">12</numbering></numberingGroup><coverDate startDate="2010-12">December 2010</coverDate></publicationMeta><publicationMeta level="unit" position="80" type="article" status="forIssue"><doi>10.1038/embor.2010.177</doi><idGroup><id type="unit" value="EMBR2010177"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Outlook</title><title type="tocHeading1">Science & Society</title><title type="tocHeading2">Outlook</title></titleGroup><copyright ownership="thirdParty">Copyright © 2010 European Molecular Biology Organization</copyright><eventGroup><event type="manuscriptReceived" date="2010-06-30"></event><event type="manuscriptAccepted" date="2010-10-18"></event><event type="publishedOnlineEarlyUnpaginated" date="2010-11-19"></event><event type="publishedOnlineFinalForm" date="2010-12-01"></event><event type="xmlConverted" agent="SPi Global Converter_TO_WileyML3Gv2.0 version:1.0; WileyML 3G Packaging Tool v1.0" date="2013-10-19"></event><event type="firstOnline" date="2010-11-19"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-16"></event></eventGroup><numberingGroup><numbering type="pageFirst">910</numbering><numbering type="pageLast">913</numbering></numberingGroup><subjectInfo><subject href="http://psi.embo.org/14693178/EMBO52">S&S: Health & Disease</subject><subject href="http://psi.embo.org/14693178/EMBO55">S&S: Politics, Policy & Law</subject></subjectInfo><linkGroup><link type="toTypesetVersion" href="file:EMBR.EMBR2010177.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Genetic tests: between risks and opportunities</title><title type="subtitle">The case of neurodegenerative diseases</title></titleGroup><creators><creator creatorRole="author" xml:id="embr2010177-cr-0001" affiliationRef="#embr2010177-aff-0001"><personName><givenNames>Donato</givenNames><familyName>Ramani</familyName></personName><biographyInfo><p>Donato Ramani and Chiara Saviane are at the Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, 34136 Trieste, Italy. E‐mails: <email>ramani@sissa.it</email>; <email>saviane@sissa.it</email></p><mediaResourceGroup><mediaResource alt="image" href="urn:x-wiley:1469221X:media:embr2010177:embr2010177-gra-0002"></mediaResource><mediaResource mimeType="image/jpg" rendition="webHiRes" alt="image" href=""></mediaResource><mediaResource mimeType="image/gif" rendition="webOriginal" alt="image" href=""></mediaResource><mediaResource mimeType="image/gif" rendition="webLoRes" alt="image" href=""></mediaResource></mediaResourceGroup></biographyInfo></creator><creator creatorRole="author" xml:id="embr2010177-cr-0002" affiliationRef="#embr2010177-aff-0001"><personName><givenNames>Chiara</givenNames><familyName>Saviane</familyName></personName><biographyInfo><p>Chiara Saviane</p><mediaResourceGroup><mediaResource alt="image" href="urn:x-wiley:1469221X:media:embr2010177:embr2010177-gra-0003"></mediaResource><mediaResource mimeType="image/jpg" rendition="webHiRes" alt="image" href=""></mediaResource><mediaResource mimeType="image/gif" rendition="webOriginal" alt="image" href=""></mediaResource><mediaResource mimeType="image/gif" rendition="webLoRes" alt="image" href=""></mediaResource></mediaResourceGroup></biographyInfo></creator></creators><affiliationGroup><affiliation countryCode="IT" type="organization" xml:id="embr2010177-aff-0001"><orgName>Interdisciplinary Laboratory for Advanced Studies, SISSA</orgName><address><street>Via Bonomea 265</street><postCode>34136</postCode><countryPart>Trieste</countryPart><country>Italy</country></address></affiliation></affiliationGroup><abstractGroup><abstract type="short"><p>Commercial genetic testing challenges traditional medical practice and the doctor–patient relationship. Neurodegenerative diseases may serve as the practical and ethical testing ground for the application of genomics to medicine.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Genetic tests: between risks and opportunities</title><subTitle>The case of neurodegenerative diseases</subTitle></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Genetic tests: between risks and opportunities</title></titleInfo><name type="personal"><namePart type="given">Donato</namePart><namePart type="family">Ramani</namePart><affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Chiara</namePart><namePart type="family">Saviane</namePart><affiliation>Interdisciplinary Laboratory for Advanced Studies, SISSA, Via Bonomea 265, Trieste, 34136, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>John Wiley & Sons, Ltd</publisher><place><placeTerm type="text">Chichester, UK</placeTerm></place><dateIssued encoding="w3cdtf">2010-12</dateIssued><dateCaptured encoding="w3cdtf">2010-06-30</dateCaptured><dateValid encoding="w3cdtf">2010-10-18</dateValid><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract type="short">Commercial genetic testing challenges traditional medical practice and the doctor–patient relationship. Neurodegenerative diseases may serve as the practical and ethical testing ground for the application of genomics to medicine.</abstract><relatedItem type="host"><titleInfo><title>EMBO reports</title></titleInfo><genre type="Journal">journal</genre><subject><genre>Index Terms</genre><topic authorityURI="http://psi.embo.org/14693178/EMBO52">S&S: Health & Disease</topic><topic authorityURI="http://psi.embo.org/14693178/EMBO55">S&S: Politics, Policy & Law</topic></subject><subject><genre>article category</genre><topic>Outlook</topic></subject><identifier type="ISSN">1469-221X</identifier><identifier type="eISSN">1469-3178</identifier><identifier type="DOI">10.1002/(ISSN)1469-3178</identifier><identifier type="PublisherID">EMBR</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><detail type="issue"><caption>no.</caption><number>12</number></detail><extent unit="pages"><start>910</start><end>913</end><total>4</total></extent></part></relatedItem><identifier type="istex">CB00405498A2F2EE7D0BD47A25168959C339EF27</identifier><identifier type="DOI">10.1038/embor.2010.177</identifier><identifier type="ArticleID">EMBR2010177</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2013 Wiley Periodicals, IncCopyright © 2010 European Molecular Biology Organization</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>John Wiley & Sons, Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002195 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002195 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:CB00405498A2F2EE7D0BD47A25168959C339EF27
|texte= Genetic tests: between risks and opportunities
}}
| This area was generated with Dilib version V0.6.23. |  |